Conquering Diseases

Study Of An Investigational Drug For Relapsing Multiple Sclerosis

Description

Seeking men and women with relapsing multiple sclerosis for a study of how effective and safe an investigational drug is compared to the usual treatment.

Overview

Participants in this study will be randomly assigned to get either the investigational drug or the standard drug used to treat relapsing multiple sclerosis. At the end of the investigational treatment period, participants will have the option of joining an extension study in which all participants will get the investigational drug.

What we're hoping for

We are studying whether an investigational drug is safe and effective in reducing relapses compared to the standard drug for relapsing multiple sclerosis.

Additional Information

ClinicalTrials.gov Identifier: NCT04338022

 Principal Investigator

Idanis  Berriosmorales, MD

UMass Memorial Health Care

 Study Contact

Kelsey  Goostrey

774-455-6567

Kelsey.Goostrey@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989